AlzeCure Pharma
AlzeCure presents at Redeye Life Science Day on November 23
AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule candidate drugs for diseases affecting the central nervous system, with projects in both Alzheimer’s disease and pain, today announced that the company is participating at Redeye Life Science Day 2023 on November 23 at 11:30 CET, where CEO Martin Jönsson will present and answer questions about the latest developments and the company's plans going forward.
Watch the livestream via https://www.redeye.se/events/915984/redeye-life-science-day-2023 where the presentation also will be available afterwards.
The presentation will also be available afterwards on AlzeCure's company page at Redeye www.redeye.se/company/alzecure-pharma, and on AlzeCure's website www.alzecurepharma.se/en/presentations-and-interviews/.
Time: 09:00-17:00 CET, November 23, 2023
Venue: Sergelkonferensen, Mäster Samuelsgatan 42 (ground floor, Redeye building), Stockholm
Datum | 2023-11-02, kl 08:00 |
Källa | MFN |
![](https://static.allaaktier.se/ads/hand-waving-2.png)